M23-385 ABBV-706 Ph 1 2L-4L SCLC
ClinicalTrials.gov NCT05599984
Research payments
$15,330
Through program year 2024, $15,330 in research payments was reported against M23-385 ABBV-706 Ph 1 2L-4L SCLC, across 20 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT05599984
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $15,330 | 20 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Afshin Dowlati Cleveland, OH Named on 1 payment
- Jiaxin Niu Gilbert, AZ Named on 1 payment
- Dhruv Bansal Overland Park, KS Named on 1 payment
- Jyoti Malhotra Duarte, CA Named on 1 payment
- Daniel Morgensztern Saint Louis, MO Named on 1 payment
- Benjamin Garmezy Nashville, TN Named on 1 payment
- Stephen Liu Los Angeles, CA Named on 1 payment
- Mustafa Khasraw New York, NY Named on 1 payment
- Sreenivasa Chandana Grand Rapids, MI Named on 1 payment
- Shirish Gadgeel Detroit, MI Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.